Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Relay Therapeutics Inc (NASDAQ: RLAY) closed at $3.6 in the last session, up 2.27% from day before closing price of $3.52. In other words, the price has increased by $2.27 from its previous closing price. On the day, 1.54 million shares were traded. RLAY stock price reached its highest trading level at $3.745 during the session, while it also had its lowest trading level at $3.49.
Ratios:
We take a closer look at RLAY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 19.96 and its Current Ratio is at 19.96. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on April 17, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $4.
On September 10, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $10.60 to $16.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 30 ’25 when Rahmer Peter sold 10,739 shares for $3.00 per share. The transaction valued at 32,217 led to the insider holds 390,081 shares of the business.
Rahmer Peter sold 1,364 shares of RLAY for $4,324 on Apr 28 ’25. The insider now owns 400,820 shares after completing the transaction at $3.17 per share. On Apr 30 ’25, another insider, Catinazzo Thomas, who serves as the Chief Financial Officer of the company, sold 12,943 shares for $3.00 each. As a result, the insider received 38,829 and left with 355,376 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 617201984 and an Enterprise Value of -69996416. For the stock, the TTM Price-to-Sale (P/S) ratio is 80.37 while its Price-to-Book (P/B) ratio in mrq is 0.85. Its current Enterprise Value per Revenue stands at -9.115 whereas that against EBITDA is 0.188.
Stock Price History:
The Beta on a monthly basis for RLAY is 1.62, which has changed by -0.4339623 over the last 52 weeks, in comparison to a change of 0.1185931 over the same period for the S&P500. Over the past 52 weeks, RLAY has reached a high of $10.72, while it has fallen to a 52-week low of $1.77. The 50-Day Moving Average of the stock is 13.99%, while the 200-Day Moving Average is calculated to be -16.75%.
Shares Statistics:
According to the various share statistics, RLAY traded on average about 2.18M shares per day over the past 3-months and 1762270 shares per day over the past 10 days. A total of 170.48M shares are outstanding, with a floating share count of 129.27M. Insiders hold about 24.60% of the company’s shares, while institutions hold 84.16% stake in the company. Shares short for RLAY as of 1749772800 were 22524543 with a Short Ratio of 10.32, compared to 1747267200 on 23159142. Therefore, it implies a Short% of Shares Outstanding of 22524543 and a Short% of Float of 15.959999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
